Fig. 1. A ) After endocytosis of SARS-CoV, cathepsin L cleaves SARS-S to S1 and S2, allowing subsequent fusion of the viral membrane with the endosomal membrane (adopted from Adedeji et al., 2013);B) Ribbon drawing structure of cathepsin L. Green ribbon: the fold of the two-chain form of native cathepsin L; Blue: α-helices; Red: β-sheets; Ball and stick: the side chains of the reactive-site cysteine (Cys25) and histidine (His163) (Turk et al., 2012); Ribbon drawing structures of C ) cystatin and oryzacystatin, D ) bromelain inhibitor VI and E ) diferric bovine lactoferrin, which show cathepsin L inhibitory activity. Bromelain inhibitor VI and lactoferrin specifically inhibit cathepsin L (no other cathepsins);F ) Structural drawings of human cathpesin L suprposed by bovine lactoferrin.